Results 61 to 70 of about 216,096 (151)

Plasma circulating cell–free DNA integrity and relative telomere length as diagnostic biomarkers for Parkinson’s disease and multiple system atrophy: a cross-sectional study

open access: yesNeural Regeneration Research
In clinical specialties focusing on neurological disorders, there is a need for comprehensive and integrated non-invasive, sensitive, and specific testing methods. Both Parkinson’s disease and multiple system atrophy are classified as α-synucleinopathies,
Chao Ying   +10 more
doaj   +1 more source

Extensive Delayed Brain Atrophy after Resuscitation in a Patient with Multiple System Atrophy

open access: yesFrontiers in Neurology, 2018
Brain magnetic resonance imaging (MRI) of multiple system atrophy (MSA) shows atrophy in the cerebrum, cerebellum, and brainstem. It is also characterized by specific patterns such as hyperintense lateral putaminal rim.
Sazuku Nisitani   +2 more
doaj   +1 more source

Linking the cerebellum posterior lobules atrophy to multiple system atrophy cognitive impairment

open access: yesNeurobiology of Disease
Background: Cognitive impairments in multiple system atrophy (MSA) are linked to cerebellar dysfunction, but the role of specific posterior cerebellar lobules in domain-specific deficits remains unclear.
Huaguang Yang   +6 more
doaj   +1 more source

Cross-examining candidate genes implicated in multiple system atrophy

open access: yesActa Neuropathologica Communications, 2019
Multiple system atrophy (MSA) is a devastating neurodegenerative disease characterized by the clinical triad of parkinsonism, cerebellar ataxia and autonomic failure, impacting on striatonigral, olivopontocerebellar and autonomic systems.
Jared S. Katzeff   +4 more
doaj   +1 more source

Can a Type-2 Diabetes Mellitus drug be hope for Multiple System Atrophy?

open access: yesAdvances in Clinical Neuroscience & Rehabilitation, 2020
Demir, Yeliz
doaj   +1 more source

A mouse model of adult-onset multiple system atrophy

open access: yesNeurobiology of Disease, 2019
Multiple system atrophy (MSA) is an adult-onset neurodegenerative disorder clinically characterized by autonomic failure in addition to various combinations of symptoms of parkinsonism, cerebellar ataxia, and pyramidal dysfunction.
Kunikazu Tanji   +7 more
doaj   +1 more source

Natural history and 12-month progression of multiple system atrophy in a Chinese cohort

open access: yesBMC Neurology
Background Understanding disease natural history is important for the development of potential treatments for people with MSA. We describe the natural progression of early MSA in a Chinese population.
Tao Feng   +15 more
doaj   +1 more source

Cognitive impairment in multiple system atrophy: Changing concepts

open access: yesDementia & Neuropsychologia
Multiple system atrophy (MSA) is characterized by a variable combination of cerebellar ataxia, parkinsonism and pyramidal signs associated with autonomic failure. Classically, cognitive impairment was not considered a clinical feature of MSA and dementia
Agessandro Abrahão   +5 more
doaj   +1 more source

Editorial: Autonomic dysfunction in multiple system atrophy

open access: yesFrontiers in Neurology, 2022
Tatsuya Yamamoto   +3 more
doaj   +1 more source

Rifampicin for multiple system atrophy [PDF]

open access: yesThe Lancet Neurology, 2014
Gregor K, Wenning   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy